When it comes to your health and weight, you deserve more than a one-size-fits-all approach
Peptide combination rationale: Anti-VEGF addresses neovascularization directly
Future trials should integrate sex-stratified endpoints to enhance therapeutic precision and equity in obesity care
7, 2023 Novartis AG has synthesized glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, obesity, hypertension, stroke, hyperglycemia, dyslipidemia, nonalcoholic steatohepatitis and diabetic nephropathy, among others
Niosomal formulation for antibacterial applications
In line with previous findings, SFN impeded TNF--induced phosphorylation of IB and significantly decreased IL-1 expression